Wall Street too giddy over vaccines: economist

Spartan Capital Securities chief market economist Peter Cardillo tells Reuters Fred Katayama investors are overly optimistic on the impact of vaccines as AstraZeneca's trial data comes under question.

He also provides his view on retailers' prospects for the holiday shopping season.